RepliCel Life 751,318 shares for debt

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学
Published on: Oct 10, 2019

The TSX Venture Exchange has accepted for filing the RepliCel Life‘s proposal to issue 751,318 shares at a deemed price of 28 cents per share to settle outstanding debt for $210,369.

Number of creditors:  five creditors

Insiders:  Andrew Schutte, $166,869.84, 595,963 shares at 28 cents; Peter Lewis, $9,750, 34,821 shares at 28 cents; Geoff MacKay, $9,750, 34,821 shares at 28 cents; David Hall, $14,250, 50,892 shares at 28 cents; Peter Lowry, $9,750, 34,821 shares at 28 cents

The company shall issue a news release when the shares are issued and the debt extinguished.

© 2019 Canjex Publishing Ltd. All rights reserved.

Biotechnology Genomics Medical Device